Educational & Research Use Only. Not medical advice. Compounds are research-grade and not FDA-approved unless explicitly noted.
06
Section 06 · 6 compounds compounds

Immune & Inflammatory Modulation

Calibrating immune defense — strengthening the weak signal, quieting the loud one.

Home/ Sections/ Immune & Inflammatory Modulation

Immunity is balance — too quiet and pathogens advance, too loud and the body attacks itself. These peptides are studied as immune modulators: amplifying defense where signals have gone weak, calibrating response where they've grown harsh.

Click any peptide below to expand. Each entry covers what it is, what it's being studied to do, why it matters, potential impact, and common research pairings, with quick facts in the sidebar.

28 Amino Acids · Decades of Clinical Use Worldwide

Thymosin Alpha-1 is a naturally occurring 28-amino-acid peptide produced by the thymus gland — the organ where T-cells mature. It plays a central role in T-cell development and function. Synthetic Tα1 has been used clinically in many countries for decades (hepatitis, cancer adjunct, immune-compromised states) and is one of the most studied immune-modulating peptides in research.

What It's Being Studied To Do

  • Enhance T-cell maturation and function (especially CD4+ and CD8+)
  • Improve immune response to viral, bacterial, and fungal infections
  • Modulate inflammatory cytokine production to prevent overactivation
  • Strengthen immune surveillance and recognition of threats
  • Support recovery in immunocompromised or stressed states
  • Promote balanced innate and adaptive immunity without broad suppression

Why This Matters

Chronic immune imbalance leads to persistent fatigue, frequent illnesses, lingering inflammation, and autoimmune flares. Thymosin Alpha-1 research explores how reinforcing thymic signaling might help restore coordinated defense and resolution — vigilant yet peaceful protection that preserves energy and tissue health.

Potential Impact Being Explored

Improved T-cell counts and function in immune-deficient models, better viral clearance (hepatitis, COVID adjunct research), reduced excessive inflammation, enhanced vaccine responses, and overall support for resilience in aging, stress, or chronic illness — frequently described as a "master regulator" of immune harmony.

Common Research Pairings

LL-37 · antimicrobial defenseVIP · anti-inflammatory synergyKPV · cytokine modulationNAD+ / glutathione · cellular support

37 Amino Acids · The Body's Front-Line Defender

LL-37 (also known as cathelicidin) is the body's primary front-line antimicrobial peptide. Naturally produced by epithelial cells, neutrophils, and other immune cells, it's a 37-amino-acid molecule that disrupts the membranes of bacteria, viruses, and fungi on contact. Synthetic LL-37 is studied for both its broad-spectrum antimicrobial properties and its immunomodulatory role.

What It's Being Studied To Do

  • Directly disrupt bacterial, viral, and fungal membranes
  • Promote wound healing through angiogenesis and epithelial migration
  • Modulate immune signaling — reducing excessive inflammation while enhancing chemotaxis
  • Combat biofilms and chronic infections
  • Enhance innate immune coordination
  • Provide antiviral effects (including in respiratory and systemic models)

Why This Matters

Chronic or hidden infections, biofilms, and dysregulated innate responses contribute to ongoing inflammation, poor healing, and systemic fatigue. LL-37 research explores how bolstering this natural host-defense peptide might help restore effective frontline protection and quick resolution.

Potential Impact Being Explored

Strong antimicrobial activity against resistant strains, accelerated wound closure, reduced biofilm formation, balanced inflammatory responses during infection, and improved outcomes in chronic wounds, respiratory infections, or skin barrier compromise.

Common Research Pairings

Thymosin Alpha-1 · innate + adaptiveVIP / KPV · inflammation controlBPC-157 · wound and vascular supportGlutathione · antioxidant protection

28 Amino Acids · Vasodilator + Anti-Inflammatory

VIP is a naturally occurring 28-amino-acid neuropeptide produced in the gut, brain, and immune cells. It's a multitasker: a potent vasodilator, a powerful anti-inflammatory mediator, and a neuroimmune regulator all in one. Researchers have studied it clinically in pulmonary hypertension and inflammatory diseases, though it isn't broadly FDA-approved.

What It's Being Studied To Do

  • Reduce pro-inflammatory cytokines (TNF-α, IL-6, etc.)
  • Promote immune tolerance and regulatory T-cell activity
  • Support respiratory and lung function — bronchodilation, mucus regulation
  • Enhance vasodilation and tissue oxygenation
  • Modulate autoimmune-like signaling
  • Protect tissues under chronic inflammatory or hypoxic stress

Why This Matters

Excessive inflammation damages tissues and impairs healing — especially in lungs, gut, or joints where oxygen and blood flow are critical. VIP research explores how this natural "peacekeeper" might help restore calm, balanced immune responses and improve circulation.

Potential Impact Being Explored

Studies in asthma, IBD, arthritis, and pulmonary models suggest reduced inflammatory markers, improved lung function and oxygen delivery, enhanced gut barrier integrity, better tolerance in autoimmune-like conditions, decreased pain and tissue damage, and overall support for neuroimmune harmony.

Common Research Pairings

Thymosin Alpha-1 · immune balanceLL-37 · antimicrobial + anti-inflammatoryKPV · cytokine controlARA-290 · tissue protection

11 Amino Acids · Selective Tissue-Protective EPO Receptor

ARA-290 is an 11-amino-acid peptide derived from erythropoietin (EPO) but engineered with surgical precision: it activates the tissue-protective EPO receptor without stimulating red blood cell production. The result is the protective benefits of EPO without the hematologic risks. It has been in clinical trials for neuropathic pain and other conditions.

What It's Being Studied To Do

  • Reduce neuropathic pain signaling
  • Support small-fiber nerve repair and regeneration
  • Modulate inflammatory pathways in nerves and tissues
  • Improve microvascular function and blood flow
  • Protect tissues under inflammatory or metabolic stress (e.g., diabetes-related neuropathy, sarcoidosis)
  • Enhance nerve conduction and sensory recovery

Why This Matters

Neuropathic pain, tingling, numbness, and small-fiber damage cause significant suffering and reduced quality of life — often from diabetes, autoimmune issues, or chronic inflammation. ARA-290 research explores how selective activation of innate repair receptors might help calm nerve inflammation and promote regeneration.

Potential Impact Being Explored

Phase II/III trial data and preclinical studies report meaningful reductions in neuropathic pain scores, improved nerve fiber density and function, better sensory thresholds, decreased inflammatory markers in neural tissue, and enhanced quality-of-life markers — particularly in diabetic neuropathy and sarcoidosis-associated small-fiber neuropathy.

Common Research Pairings

VIP · anti-inflammatory + vascularThymosin Alpha-1 · immune coordinationNAD+ / glutathione · neuronal supportBPC-157 · nerve/tissue repair synergy

Tetrapeptide Bioregulator · Russian-developed

Bronchogen is a short-chain peptide bioregulator (Ala-Glu-Asp-Pro) developed at the St. Petersburg Institute of Bioregulation under the Khavinson research school. It targets the bronchopulmonary epithelium specifically — the cells lining the airways — where it is studied for its ability to support cellular renewal, modulate inflammation, and restore tissue-specific gene expression patterns that decline with age and chronic stress.

Plain-Language PictureImagine a small key that fits the lock on the cells lining your airways. Bronchogen is studied as that key — encouraging tired bronchial cells to remember how to repair themselves, at their original pace.

What It's Being Studied To Do

  • Stimulate regeneration of bronchial epithelial cells under chronic stress conditions
  • Reduce chronic inflammation in airway tissue without immunosuppression
  • Support mucociliary clearance — the airway's natural self-cleaning function
  • Modulate immune response within pulmonary tissue specifically
  • Improve cellular recovery in research models of respiratory aging and oxidative damage

Why This Matters

Lung epithelium is one of the most-exposed tissues in the body — it endures pollutants, pathogens, and oxidative damage with every breath. Bronchogen research explores supporting the bronchi's natural repair signaling rather than overriding it with broad-spectrum drugs.

Potential Impact Being Explored

Improved markers of bronchial cell renewal, reduced chronic inflammation, and supportive findings in COPD-adjacent and age-related lung function research.

Common Research Pairings

Chonluten · pulmonary co-bioregulatorThymosin Alpha-1 · immune balanceGlutathione · antioxidant supportVIP · airway smooth-muscle modulation

Tripeptide Bioregulator · Russian-developed

Chonluten is a synthetic tripeptide (Glu-Asp-Gly) bioregulator developed alongside Bronchogen at the St. Petersburg Institute of Bioregulation. Like other Khavinson peptides, it is studied as a tissue-specific signal — in this case directed at bronchopulmonary cells — to support their natural regulatory cycles at the level of gene expression itself.

Plain-Language PictureWhere Bronchogen knocks gently on the lung's repair door, Chonluten is studied as the molecule that reminds the lung's regulatory clock when it's time to start the workday again.

What It's Being Studied To Do

  • Normalize bronchial cell function in chronic stress and aging research models
  • Reduce oxidative damage in pulmonary tissue
  • Support gene expression patterns associated with epithelial renewal
  • Improve mucociliary clearance and airway integrity
  • Modulate inflammatory cytokine balance in airway tissue without suppression

Why This Matters

As the body ages, tissue-specific repair signals weaken. Khavinson-style bioregulators are studied for their ability to gently restore those signals at the level of the genome itself — encouraging cells to resume their original maintenance schedule rather than overstimulating them with foreign signaling.

Potential Impact Being Explored

Encouraging findings in chronic obstructive pulmonary disease research, age-related lung function decline, and pulmonary oxidative-stress recovery models.

Common Research Pairings

Bronchogen · paired pulmonary bioregulatorEpitalon · longevity bioregulatorCartalax · cartilage bioregulatorNAD+ · cellular energy
← 05 · Neurological Repair & Neurocognitive Support 07 · Melanocortin System & Pigmentation Signaling →